Helion
Helion Announces $465M Series G Led by Thrive Capital
Helion announced $465M in Series G financing on June 4, 2026. Helion announced a $465 million Series G led by Thrive Capital to accelerate commercial fusion deployment, scale manufacturing capacity, and deliver clean electricity to customers. The company later noted that the oversubscribed round closed at $500 million in September 2026.
Round details
The financing includes backing from Thrive Capital, Lux Capital, Peak XV Partners, Alta Park Capital, Anti Fund, BoxGroup, Lightspeed Venture Partners, SoftBank Vision Fund 2. The company reported a $15.5B post-money valuation alongside the transaction.
- Round: Series G
- Capital announced: $465M
- Total funding reported: $1.5B
- Headquarters: Everett, WA
How the company plans to use the capital
Helion said the funding will accelerate commercial deployment of fusion, scale manufacturing capacity, and expand the company’s ability to deliver clean electricity to customers.
Why this matters for GTM teams
Helion said the round was led by Thrive Capital and included both new and existing investors.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Helion Series G announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


